CStone Pharmaceuticals (HKG:2616)
Hong Kong · Delayed Price · Currency is HKD 5.07
-0.02 (-0.29%)
Oct 21, 2026, 2:54 PM HKT
CStone Pharmaceuticals Market Cap
CStone Pharmaceuticals has a market cap or net worth of 8.07 billion as of October 20, 2026. It is the 9,937th most valuable company in the world and the 500th biggest in Hong Kong. Its market cap has decreased by 20.34% in one year.
Market Cap
8.07B
Enterprise Value
6.60B
Revenue
490.92M
Global Rank
Country Rank
#500 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since February 26, 2019, CStone Pharmaceuticals's market cap has decreased from 12.65B to 8.07B, a decrease of -36.23%. That is a compound annual growth rate of -5.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 8.07B | 3.89% |
| Dec 31, 2025 | 7.77B | 164.57% |
| Dec 31, 2024 | 2.94B | 1.52% |
| Dec 29, 2023 | 2.89B | -47.58% |
| Dec 30, 2022 | 5.52B | -42.71% |
| Dec 31, 2021 | 9.63B | -16.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ascentage Pharma Group International | 10.94B |
| GenFleet Therapeutics (Shanghai) | 10.32B |
| Suzhou Ribo Life Science | 8.63B |
| HBM Holdings | 8.56B |
| Nanjing Leads Biolabs | 8.06B |
| Shaanxi Micot Pharmaceutical Technology | 7.96B |
| Shanghai Haohai Biological Technology | 7.18B |
| Alphamab Oncology | 6.68B |